The typical escalation looks like this: Weeks 1 through 4: 0.25 mg per week (adjustment phase, minimal visible effects) Weeks 5 through 8: 0.5 mg per week (appetite suppression becomes more consistent) Weeks 9 through 12: 1.0 mg per week (significant appetite reduction, weight loss accelerates) Weeks 13 through 16: 1.7 mg per week (strong effects for most users) Week 17 onward: 2.4 mg per week (full therapeutic dose) Each dose increase brings a noticeable step up in effect intensity
Surgical Complications: Though rare in 2026, risks include staple line leaks, internal hernias, or bowel obstructions
A2: Yes, Semaglutide is approved for weight loss in individuals without diabetes, but it should only be used under the supervision of a healthcare provider
At baseline, 16.6% of the population reported retinopathy
Ozempic is licensed for type 2 diabetes (though its sometimes used off-label for weight loss), while Wegovy is licensed for weight loss